MetLife Investment Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.79M | Sell |
|
|||||
|
2025
Q2 | $10.3M | Sell |
|
|||||
|
2025
Q1 | $8.09M | Sell |
|
|||||
|
2024
Q4 | $9.38M | Sell |
|
|||||
|
2024
Q3 | $8.21M | Sell |
|
|||||
|
2024
Q2 | $14.1M | Buy |
|
|||||
|
2024
Q1 | $14.7M | Sell |
|
|||||
|
2023
Q4 | $13.6M | Sell |
|
|||||
|
2023
Q3 | $10.5M | Sell |
|
|||||
|
2023
Q2 | $14.7M | Sell |
|
|||||
|
2023
Q1 | $13.4M | Sell |
|
|||||
|
2022
Q4 | $13.2M | Sell |
|
|||||
|
2022
Q3 | $9.7M | Sell |
|
|||||
|
2022
Q2 | $9.07M | Sell |
|
|||||
|
2022
Q1 | $15.7M | Buy |
|
|||||
|
2021
Q4 | $11.5M | Sell |
|
|||||
|
2021
Q3 | $12M | Sell |
|
|||||
|
2021
Q2 | $9.57M | Sell |
|
|||||
|
2021
Q1 | $8.24M | Sell |
|
|||||
|
2020
Q4 | $8.62M | Sell |
|
|||||
|
2020
Q3 | $10M | Buy |
|
|||||
|
2020
Q2 | $9.79M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $14.3K | Buy |
|
|||||
|
2018
Q4 | $14.3K | Sell |
|
|||||
|
2018
Q3 | $17.2K | Buy |
|